RAC 0.00% $1.55 race oncology ltd

Seems this paper is promotional material for the development of...

  1. 2,710 Posts.
    lightbulb Created with Sketch. 2425
    Seems this paper is promotional material for the development of new inhibitors ... the research says Xantrene stacks up fine in these areas, we're in the clinic and will have results flowing from that shortly.

    The good part of the paper for us is just how widely in cancer and other medicine FTO is important.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.